GSTM1 and urothelial carcinoma: Aberrant methylation of GSTM1 has been found in various cancers, such as acute myeloid leukaemia, urothelial carcinoma and head and neck cancer (Sharma et al., 2010; Ohgami et al., 2012; Wang et al., 2016).